Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has shared an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced a final cash dividend of RMB 2.9 per 10 shares for the financial year ending December 31, 2024, with the payment to be made in Hong Kong dollars. The dividend will be paid on August 25, 2025, following shareholder approval on June 26, 2025. The announcement includes details on withholding tax rates applicable to different categories of shareholders, reflecting the company’s compliance with international tax treaties and regulations. This dividend declaration underscores the company’s commitment to returning value to its shareholders and may impact its market positioning and investor relations positively.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is a significant player in the Chinese market, providing a wide range of medical and healthcare products.
Average Trading Volume: 7,261,365
Technical Sentiment Signal: Hold
Current Market Cap: HK$65.18B
For a thorough assessment of 2607 stock, go to TipRanks’ Stock Analysis page.